Disease-specific and event-free survival in breast cancer patients: A hospital-based study between 1990 and 2001

Revue d'Epidemiologie et de Sante Publique

Volumn 54, Issue 4, 2006, Pages 313-325

  Mallol, N ^a   Desandes, E ^a   Lesur Schwander, A ^a   Guillemin, F ^a  

^a CENTRE ALEXIS VAUTRIN   (France)

Author keywords

Breast Cancer; Epidemiology; Survival

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER REGISTRY; CANCER REGRESSION; CANCER RELAPSE; CANCER SURVIVAL; CANCER THERAPY; CARCINOMA IN SITU; CAUSE OF DEATH; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; METASTASIS; PROGNOSIS; PROPORTIONAL HAZARDS MODEL;

EID: 33750249013     PISSN: 03987620     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0398-7620(06)76727-X     Document Type: Article

References (32)

1. Remontet L, Esteve J, Bouvier AM, Grosclaude P, Launoy G, Menegoz F, et al. Cancer incidence and mortality in France over the period 1978-2000. Rev Epidemiol Sante Publique 2003; 51: 3-30.
2. Hill C, Doyon F. Frequency of cancer in France: 2004 update. Bull Cancer 2004; 91: 9-14.
3. Tretarre B. Sein. In: Remontet L, Buemi A, Velten M, Jougla E, Esteve J, eds. Evolution de l'incidence et de la mortlité par cancer en France de 1978 à 2000. Saint-Maurice: Institut de Veille Sanitaire (InVS), 2002. 99-106. http://www.invs.sante.fr/publications/2003/rapport_cancer_/p99_sein.pdf [Accessed 26 July 4].
4. Peto R, Boreham J, Clarke M, Davies C, Beral V. UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years. Lancet 2000; 355: 1822.
5. Thomson CS, Brewster DH, Dewar JA, Twelves CJ. Improvements in survival for women with breast cancer in Scotland between 1987 and 1993: impact of earlier diagnosis and changes in treatment. Eur J Cancer 2004; 40: 743-53.
6. American Joint Committee on Cancer. AJCC Cancer Staging Manual. 5th ed. Philadelphia: Lippincott-Raven, 1997.
7. Percy CVH, Muir C. International classification of diseases for oncology. 2nd ed. Geneva: World Health Organization, 1992.
8. Bloom HJ, Richardson WW. Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 1957; 11: 359-77.
9. Shuster JJ. Median follow-up in clinical trials. J Clin Oncol 1991; 9: 191-2.
10. Kaplan E, Meier P. Non-parametric estimation from incomplete observation. J Am Stat Assoc 1958; 53: 457-81.
11. SPSS. Statistical package for Social Sciences (version 9.0). Chertsey: SPSS Inc, 1998.
12. Grosclaude P, Colonna M, Hedelin G, Tretarre B, Arveux P, Lesec'h JM, et al. Survival of women with breast cancer in france: variation with age, stage and treatment. Breast Cancer Res Treat 2001; 70: 137-43.
13. Ugnat AM, Xie L, Morriss J, Semenciw R, Mao Y. Survival of women with breast cancer in Ottawa, Canada: variation with age, stage, histology, grade and treatment. Br J Cancer 2004; 90: 1138-43.
14. Tejler G, Norberg B, Dufmats M, Nordenskjold B. Survival after treatment for breast cancer in a geographically defined population. Br J Surg 2004; 91: 1307-12.
15. Minelli L, Stracci F, Prandini S, Falsettini E, Fusco-Moffa I, La Rosa F. Breast cancer incidence, mortality and survival in the Umbria region of Italy (1978-1999). Eur J Cancer Prev 2004; 13: 485-9.
16. Christensen LH, Engholm G, Ceberg J, Hein S, Perfekt R, Tange UB, et al. Can the survival difference between breast cancer patients in Denmark and Sweden 1989 and 1994 be explained by patho-anatomical variables? A population-based study. Eur J Cancer 2004; 40: 1233-43.
17. Taylor R, Davis P, Boyages J. Long-term survival of women with breast cancer in New South Wales. Eur J Cancer 2003; 39: 215-22.
18. Webb PM, Cummings MC, Bain CJ, Furnival CM. Changes in survival after breast cancer: improvements in diagnosis or treatment? Breast 2004; 13: 7-14.
19. Giordano SH, Buzdar AU, Smith TL, Kau SW, Yang Y, Hortobagyi GN. Is breast cancer survival improving? Cancer 2004; 100: 44-52.
20. Maggard MA, O'Connell JB, Lane KE, Liu JH, Etzioni DA, Ko CY. Do young breast cancer patients have worse outcomes? J Surg Res 2003; 113: 109-13.
21. Mersin H, Yildirim E, Gulben K, Berberoglu U. Is invasive lobular carcinoma different from invasive ductal carcinoma? Eur J Surg Oncol 2003; 29: 390-5.
22. Rutgers EJ. Follow-up care in breast cancer. Expert Rev Anticancer Ther 2004; 4: 212-8.
23. Jager JJ, Volovics L, Schouten LJ, De Jong JM, Hupperets PS, Von Meyenfeldt MF, et al. Loco-regional recurrences after mastectomy in breast cancer: prognostic factors and implications for postoperative irradiation. Radiother Oncol 1999; 50: 267-75.
24. Bernstein JL, Lapinski RH, Thakore SS, Doucette JT, Thompson WD. The descriptive epidemiology of second primary breast cancer. Epidemiology 2003; 14: 552-8.
25. Kurtz JM, Spitalier JM, Amalric R, Brandone H, Ayme Y, Jacquemier J, et al. The prognostic significance of late local recurrence after breast-conserving therapy. Int J Radiat Oncol Biol Phys 1990; 18: 87-93.
26. Patz EF Jr, Goodman PC, Bepler G. Screening for lung cancer. N Engl J Med 2000; 343: 1627-33.
27. French Adjuvant Study Group. Benefit of a high-dose epirubicin regimen in adjuvant chemotherapy for node-positive breast cancer patients with poor prognostic factors: 5-year follow-up results of French Adjuvant Study Group 05 randomized trial. J Clin Oncol 2001; 19: 602-11.
28. Cole BF, Gelber RD, Gelber S, Coates AS, Goldhirsch A. Polychemotherapy for early breast cancer: an overview of the randomised clinical trials with quality-adjusted survival analysis. Lancet 2001; 358: 277-86.
29. Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet 1998; 351: 1451-67.
30. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005; 365: 1687-717.
31. Clarke M, Collins R, Darby S, Davies C, Elphinstone P, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005; 366: 2087-106.
32. Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 2005; 353: 1784-92.